Miriam Braunstein

Title: Miriam Braunstein: Innovator in Mycobacterial Research

Introduction

Miriam Braunstein is a prominent inventor based in Chapel Hill, NC (US). She has made significant contributions to the field of mycobacterial research, particularly in understanding host-pathogen interactions. With a total of 2 patents, her work has implications for developing new therapeutic strategies against mycobacterial infections.

Latest Patents

Braunstein's latest patents include innovative approaches to manipulating mycobacterial mutants. One patent focuses on "Mycobacterial mutants affecting host apoptosis," which provides recombinant strains with mutations in the nlaA or nuoG genes. This patent also details methods for inducing an immune response in mammals using these mutants. Another significant patent is for "Mycobacterial SecA2 mutants," which describes mycobacteria with mutations that attenuate virulence in mammalian hosts. This patent outlines methods for inducing immune responses to pathogenic mycobacteria in humans.

Career Highlights

Throughout her career, Braunstein has worked at esteemed institutions such as the Albert Einstein College of Medicine and the University of North Carolina at Chapel Hill. Her research has been pivotal in advancing our understanding of mycobacterial biology and its interactions with the immune system.

Collaborations

Braunstein has collaborated with notable scientists, including William R. Jacobs, Jr. and Steven A. Porcelli. These collaborations have further enriched her research and contributed to the scientific community's knowledge of mycobacterial diseases.

Conclusion

Miriam Braunstein's innovative work in mycobacterial research has led to valuable patents that enhance our understanding of host-pathogen interactions. Her contributions continue to influence the field and pave the way for future advancements in therapeutic strategies.